Related references
Note: Only part of the references are listed.Analysis of Unbiased Histopathology Data from Rodent Toxicity Studies (or, Are These Groups Different Enough to Ascribe It to Treatment?)
Tom Holland et al.
TOXICOLOGIC PATHOLOGY (2011)
Response to Letter to Editor by Dr. J. C. Wolf on Analysis of unbiased histopathology data from rodent toxicity studies (or, are these groups different enough to ascribe it to treatment?)
Tom Holland et al.
TOXICOLOGIC PATHOLOGY (2011)
Concerning the Analysis of Unbiased Histopathology Data
Stuart Levin
TOXICOLOGIC PATHOLOGY (2011)
Sponsor-CRO Practices That Facilitate the Creation of a High-Quality Pathology Report: A Pharmaceutical Sponsor's Perspective
Armando R. Irizarry Rovira et al.
TOXICOLOGIC PATHOLOGY (2011)
Counterpoint to Analysis of Unbiased Histopathology Data from Rodent Toxicity Studies (or, Are These Groups Different Enough to Ascribe to Treatment?)
Jeffrey C. Wolf
TOXICOLOGIC PATHOLOGY (2011)
Recommendations for the Evaluation of Pathology Data in Nonclinical Safety Biomarker Qualification Studies
John E. Burkhardt et al.
TOXICOLOGIC PATHOLOGY (2011)
The comparative power of the discriminant methods used in toxicological pathology
T Holland
TOXICOLOGIC PATHOLOGY (2005)
Best practices guideline: T6oxicologic histopathology
JW Crissman et al.
TOXICOLOGIC PATHOLOGY (2004)
Share Paper
